https://orcid.org/0000-0002-7448-2984
References
- FDA. 1998. Guidance for industry: Providing clinical evidence of effectiveness for human drug and biological products. Rockville: MD.
- Gehan, E. A., and E. J. Freireich. 1974. Non-randomized controls in cancer clinical trials. The New England Journal of Medicine 290 (4):198–203. doi:10.1056/NEJM197401242900405.
- Hainmueller, J. 2012. Entropy balancing for causal effects: A multivariate reweighting method to produce balanced samples in observational studies. Political Analysis 20 (1):25–46. doi:10.1093/pan/mpr025.
- Hatswell, A. J., G. Baio, J. A. Berlin, A. Irs, and N. Freemantle. 2016. Regulatory approval of pharmaceuticals without a randomised controlled study: Analysis of ema and fda approvals 1999–2014. BMJ open 6 (6):e011666. doi:10.1136/bmjopen-2016-011666.
- Hernán, M. A., S. Hernández-Daz, and J. M. Robins. 2004. A structural approach to selection bias. Epidemiology 15 (5):615–625. doi:10.1097/01.ede.0000135174.63482.43.
- Klungel, O. H., E. P. Martens, B. M. Psaty, D. E. Grobbee, S. D. Sullivan, B. H. C. Stricker, H. G. Leufkens, and A. De Boer. 2004. Methods to assess intended effects of drug treatment in observational studies are reviewed. Journal of Clinical Epidemiology 57 (12):1223–1231. doi:10.1016/j.jclinepi.2004.03.011.
- Lechner, M. 2001. Identification and estimation of causal effects of multiple treatments under the conditional Independence assumption. In Econometric evaluation of labour market policies, 43–58. Physica, Heidelberg.
- Lechner, M. 2002. Program heterogeneity and propensity score matching: An application to the evaluation of active labor market policies. Review of Economics and Statistics 84 (2):205–220. doi:10.1162/003465302317411488.
- Lin, J., M. Gamalo-Siebers, and R. Tiwari. 2018. Propensity score matched augmented controls in randomized clinical trials: A case study. Pharmaceutical Statistics 17 (5):629–647. doi:10.1002/pst.1879.
- Lin, J., M. Gamalo-Siebers, and R. Tiwari. 2019. Propensity-score-based priors for bayesian augmented control design. Pharmaceutical Statistics 18 (2):223–238. doi:10.1002/pst.1918.
- Pica, N., and F. Bourgeois. 2016. Discontinuation and nonpublication of randomized clinical trials conducted in children. Pediatrics 138 (3). doi:10.1542/peds.2016-0223.
- Rubin, D. B. 1977. Assignment to treatment group on the basis of a covariate. Journal of Educational and Behavioral Statistics 2 (1):1–26. doi:10.3102/10769986002001001.
- Yu, G., Y. Bian, and M. Gamalo. 2022. Power priors with entropy balancing weights in data augmentation of partially controlled randomized trials. Journal of Biopharmaceutical Statistics 32 (1):4–20. doi:10.1080/10543406.2021.2021226.